Yearly Archives: 2023

/2023

Rollout of HRT PPC begins from April

The Government’s new Prescription Prepayment Certificate (PPC) for hormone replacement therapy (HRT) products comes into effect from tomorrow (1 April 2023). PSNC has been in discussion with the British Medical Association (BMA) about the impact of the new HRT PPC on working practices. Both we and the BMA are agreed on the importance of collaborative [...]

The post Rollout of HRT PPC begins from April appeared first on PSNC Website.

By |March 31st, 2023|Lexpos News|Comments Off on Rollout of HRT PPC begins from April

Public overwhelmingly back Pharmacy First

YouGov polling commissioned by PSNC has shown the strength of public support for pharmacies and for a Pharmacy First service. The results show the extent of the public backing for a Pharmacy First approach – PSNC has been arguing that a fully-funded service would be beneficial for pharmacies, patients and the wider NHS. And they [...]

The post Public overwhelmingly back Pharmacy First appeared first on PSNC Website.

By |March 31st, 2023|Lexpos News|Comments Off on Public overwhelmingly back Pharmacy First

MHRA Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited)

Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited) Drug alert number: EL (23)A/13 Date issued: 30 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Briviact 75 mg film-coated tablets,  PLPI 18716/0146  SNOMED Code: 37622711000001100 Batch number Expiry date [...]

The post MHRA Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited) appeared first on PSNC Website.

By |March 30th, 2023|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited)

March 2023 Price Concessions 3rd Update

The Department of Health and Social Care (DHSC) has today (30/03/2023) granted the following list of price concessions for March 2023. Drug Pack size Price concession Bicalutamide 150mg tablets 28 £3.96 Cefalexin 250mg tablets 28 £2.86 Cefalexin 500mg capsules 21 £2.80 Cefalexin 500mg tablets 21 £2.80 Cinnarizine 15mg tablets 84 £5.70 Clarithromycin 125mg/5ml oral suspension 70 [...]

The post March 2023 Price Concessions 3rd Update appeared first on PSNC Website.

By |March 30th, 2023|Lexpos News|Comments Off on March 2023 Price Concessions 3rd Update

25 products added to the Discount Not Deducted (DND) list from April 2023

Following applications made by PSNC to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), a further 25 new products were classed as ‘Drugs for which Discount is Not Deducted’ (DND) from 1 April 2023. This took the total number of products granted DND status to over 600 products following checks [...]

The post 25 products added to the Discount Not Deducted (DND) list from April 2023 appeared first on PSNC Website.

By |March 30th, 2023|Lexpos News|Comments Off on 25 products added to the Discount Not Deducted (DND) list from April 2023